生技原料市场规模、份额及成长分析（按类型、产品类型、表达系统及地区划分）－2026-2033年产业预测

预计到 2024 年，全球生技原料市场规模将达到 23.9 亿美元，到 2025 年将达到 26.1 亿美元，到 2033 年将达到 51.9 亿美元，预测期（2026-2033 年）的复合年增长率为 9%。

全球生技原料市场正经历显着成长，这主要得益于製药、农业和食品生产等各个领域对永续和创新解决方案日益增长的需求。基因工程和合成生物学等领域的生物技术进步，使得性能更优、环境效益更高的生物基原料、酵素和化学品得以开发。人们日益认识到生物技术原料有助于应对资源短缺和气候变迁等挑战，这进一步推动了其应用。然而，监管的复杂性和公众认知等挑战正在影响市场，并在市场发展和未来机会方面发挥关键作用。

全球生物技术原料市场驱动因素

全球生物技术原料市场的主要驱动力是消费者对永续植物来源产品日益增长的需求。随着消费者越来越关注自身健康和环境影响，他们对含有天然来源和环保成分的产品的需求显着增加。生物技术能够透过高效且永续的工艺生产这些成分，最大限度地减少对传统农业技术的依赖。这一趋势反映了消费者对洁净标示和透明度的偏好，进一步推动了生物技术原料在食品、化妆品和製药等各个领域的应用。总而言之，对永续性和健康的重视将继续显着影响市场动态。

全球生技原料市场面临的限制因素

由于监管障碍和公众对基因改造生物（GMO）的质疑，全球生物技术原料市场面临严峻挑战。儘管生物技术取得了长足进步，但人们对基因改造生物的安全性、环境影响和伦理问题仍然担忧，导致消费者和监管机构都感到不安。这种疑虑氛围可能导致对生物技术产品推出更严格的监管法规和标籤要求，阻碍市场扩张。为了有效克服这些障碍，产业相关人员必须优先考虑透明沟通，进行全面的安全评估，并投资于旨在建立消费者信任和消除对生物技术原料误解的教育活动。

全球生物技术原料市场趋势

全球生技原料市场正经历着变革性的趋势，这主要得益于消费者对永续和天然替代品的偏好日益增长，这些需求涵盖食品、化妆品和製药等多个领域。基因工程和生物製程的创新正在催生出独特的、高性能的原料，从而提升产品性能。同时，完善的法规结构为生物技术的发展创造了有利环境，生物技术公司与传统製造商之间的策略联盟也促进了生物技术原料融入主流产品。这反映出市场正朝着生物基解决方案的方向转变，这些解决方案符合具有环保意识的消费者的价值观，并引领市场走向更永续的未来。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 专利分析

全球生物技术原料市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 创新生物技术药物
• 生物相似药

全球生技原料市场规模（依产品及复合年增长率划分）（2026-2033 年）

• 单株抗体
• 疫苗
• 荷尔蒙和生长因子
• 细胞激素
• 融合蛋白
• 治疗酵素
• 血液因子

全球生物技术原料市场规模（按表达系统和复合年增长率划分）（2026-2033 年）

• 哺乳动物表达系统
• 微生物表现系统
• 酵母表现系统
• 植物表达系统
• 昆虫表达系统

全球生技原料市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Novo Nordisk（Denmark）
• BASF（Germany）
• Lonza Group（Switzerland）
• DSM（Netherlands）
• Evonik Industries（Germany）
• WuXi AppTec（China）
• Samsung Biologics（South Korea）
• Biocon（India）
• Dr. Reddy's Laboratories（India）
• Divi's Laboratories（India）
• Laurus Labs（India）
• Concord Biotech（India）
• Amgen（USA）
• Genentech（USA）
• Regeneron Pharmaceuticals（USA）
• Gilead Sciences（USA）
• Celgene（USA）
• Bristol Myers Squibb（USA）
• Sanofi（France）
• GlaxoSmithKline（UK）

结论与建议

Global Biotech Ingredients Market size was valued at USD 2.39 Billion in 2024 and is poised to grow from USD 2.61 Billion in 2025 to USD 5.19 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026-2033).

The global market for biotech ingredients is experiencing significant growth, driven by the rising demand for sustainable and innovative solutions across diverse sectors, including pharmaceuticals, agriculture, and food production. Advances in biotechnology, particularly in areas like genetic engineering and synthetic biology, have facilitated the creation of bio-based ingredients, enzymes, and chemicals that provide improved performance and environmental advantages. Increased awareness of how biotech ingredients can tackle issues such as resource scarcity and climate change further supports their adoption. However, the market is shaped by challenges related to regulatory complexities and public perception, which play crucial roles in influencing its development and future opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biotech Ingredients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biotech Ingredients Market Segments Analysis

Global Biotech Ingredients Market is segmented by Type, Product, Expression System and region. Based on Type, the market is segmented into Innovative Biotech Apis and Biosimilars. Based on Product, the market is segmented into Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes and Blood Factors. Based on Expression System, the market is segmented into Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems and Insect Expression Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biotech Ingredients Market

The global biotech ingredients market is primarily driven by the increasing demand for sustainable and plant-based products. As consumers grow more aware of their health and environmental impacts, there is a noticeable shift toward products containing natural and eco-friendly ingredients. Biotechnology provides the capability to produce these ingredients through efficient and sustainable processes, thereby minimizing dependency on conventional agricultural techniques. This trend reflects consumers' preferences for clean labels and transparency, further boosting the uptake of biotech ingredients in diverse sectors, including food, cosmetics, and pharmaceuticals. Overall, the emphasis on sustainability and health continues to shape market dynamics significantly.

Restraints in the Global Biotech Ingredients Market

The global biotech ingredients market faces notable challenges due to regulatory hurdles and public skepticism regarding genetically modified organisms (GMOs). Despite advancements in biotechnology, lingering concerns about the safety, environmental implications, and ethical dimensions of GMOs contribute to apprehension among consumers and regulators alike. This atmosphere of doubt fosters stricter regulations and labeling mandates for biotech products, potentially hindering market expansion. To navigate these obstacles effectively, it is essential for industry participants to prioritize transparent communication, conduct thorough safety evaluations, and invest in educational initiatives aimed at building consumer trust and dispelling myths related to biotech ingredients.

Market Trends of the Global Biotech Ingredients Market

The global biotech ingredients market is experiencing transformative trends fueled by a rising consumer preference for sustainable and natural alternatives across multiple sectors, including food, cosmetics, and pharmaceuticals. Innovations in genetic engineering and bioprocessing are leading to the creation of unique, high-performance ingredients, enhancing product offerings. Concurrently, supportive regulatory frameworks are nurturing an environment ripe for biotech advancements, with strategic partnerships between biotech companies and traditional manufacturers enhancing integration into mainstream products. This landscape reflects a broader shift towards bio-based solutions, aligning with the values of environmentally conscious consumers and driving the market toward a more sustainable future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Biotech Ingredients Market Size by Type & CAGR (2026-2033)

• Market Overview
• Innovative Biotech Apis
• Biosimilars

Global Biotech Ingredients Market Size by Product & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors

Global Biotech Ingredients Market Size by Expression System & CAGR (2026-2033)

• Market Overview
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems

Global Biotech Ingredients Market Size & CAGR (2026-2033)

• North America (Type, Product, Expression System)
  • US
  • Canada
• Europe (Type, Product, Expression System)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Expression System)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Expression System)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Expression System)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Divi's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laurus Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concord Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations